Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed May 19, 2022

Accession no.
0001209191-22-030309
Filed
May 19, 2022, 7:32 AM ET
Trade date
May 18, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market purchases total $144.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 18, 2022Common StockPPurchaseAcquired+6,806$2.86+$19,465.16195,913,500Indirect
May 18, 2022Common StockPPurchaseAcquired+2,970$2.87+$8,509.05195,916,470Indirect
May 18, 2022Common StockPPurchaseAcquired+5,224$2.87+$14,992.88195,921,694Indirect
May 18, 2022Common StockPPurchaseAcquired+25,000$2.88+$71,875195,946,694Indirect
May 18, 2022Common StockPPurchaseAcquired+1,650$2.91+$4,801.5195,948,344Indirect
May 18, 2022Common StockPPurchaseAcquired+8,350$2.92+$24,340.25195,956,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)